MRI in the Diagnosis and Monitoring of Multiple Sclerosis: An Update

详细信息    查看全文

• 作者：M. P. Wattjes ; M. D. Steenwijk MSc ; M. Stangel MD
• 关键词：Multiple sclerosis ; MRI ; Disease monitoring ; Safety monitoring ; PML
• 刊名：Clinical Neuroradiology
• 出版年：2015
• 出版时间：October 2015
• 年：2015
• 卷：25
• 期：2-supp
• 页码：157-165
• 全文大小：857 KB
• 参考文献：1.Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292-02.PubMed Central CrossRef PubMed
  2.Rovira A, Wattjes MP, Tintoré M, Tur C, Yousry TA, Sormani MP, De Stefano N, Filippi M, Auger C, Rocca MA, Barkhof F, Fazekas F, Kappos L, Polman C, Miller D, Montalban X; MAGNIMS study group. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol. 2015 Jul 7. [Epub ahead of print].
  3.Wattjes MP, Rovira A, Miller DH, Yousry T, Sormani MP, de Stefano N, Tintoré M, Auger C, Tur C, Filippi M, Rocca MA, Fazekas F, Kappos L, Polman C, Barkhof F, Montalban X, on behalf of the MAGNIMS study group. MAGNIMS consensus guidelines on MR imaging in multiple sclerosis. MR imaging in multiple sclerosis disease prognosis and monitoring. Nat Rev Neurol. 2015 (submitted).
  4.Petzold A, Wattjes MP, Costello F, Flores-Rivera J, Fraser CL, Fujihara K, Leavitt J, Marignier R, Paul F, Schippling S, Sindic C, Villoslada P, Weinshenker B, Plant GT. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014;10:447-8.CrossRef PubMed
  5.Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol. 2002;15:239-5.CrossRef PubMed
  6.Filippi M, Preziosa P, Rocca MA. Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink? Curr Opin Neurol. 2014;27:290-.CrossRef PubMed
  7.Wattjes MP, Lutterbey GG, Harzheim M, Gieseke J, Tr?ber F, Klotz L, Klockgether T, Schild HH. Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5?T with 3.0?T. Eur Radiol. 2006;16:2067-3.CrossRef PubMed
  8.Wattjes MP, Harzheim M, Lutterbey GG, Hojati F, Simon B, Schmidt S, Schild HH, Barkhof F. Does high field MRI allow an earlier diagnosis of multiple sclerosis? J Neurol. 2008;255:1159-3.CrossRef PubMed
  9.Gass A, Rocca MA, Agosta A, Ciccarelli O, Chard D, Valsasina P, Brooks JC, Bischof A, Eisele P, Kappos L, Barkhof F, Filippi M; MAGNIMS Study Group. MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis. Lancet Neurol. 2015;14:443-4.CrossRef PubMed
  10.Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, Hauser SL, Pelletier D. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72(9):800-5. Erratum in: Neurology. 2009;72(14):1284.CrossRef
  11.Pestalozza IF, Pozzilli C, Di Legge S, Piattella MC, Pantano P, Caramia F, Pasqualetti P, Lenzi GL. Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome. Mult Scler. 2005;11:390-.CrossRef PubMed
  12.Sombekke MH, Wattjes MP, Balk LJ, Nielsen JM, Vrenken H, Uitdehaag BM, Polman CH, Barkhof F. Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology. 2013;80:69-5.CrossRef PubMed
  13.Tumani H, Deisenhammer F, Giovannoni G, Gold R, Hartung HP, Hemmer B, Hohlfeld R, Otto M, Stangel M, Wildemann B, Zettl UK. Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis. Ann Neurol. 2011;70:520.CrossRef PubMed
  14.Bot JC, Barkhof F, Lycklama à Nijeholt G, van Schaardenburg D, Voskuyl AE, Ader HJ, Pijnenburg JA, Polman CH, Uitdehaag BM, Vermeulen EG, Castelijns JA. Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology. 2002;223:46-6.CrossRef PubMed
  15.Kilsdonk ID, Wattjes MP, Lopez-Soriano A, Kuijer JP, de Jong MC, de Graaf WL, Conijn MM, Polman CH, Luijten PR, Geurts JJ, Geerlings MI, Barkhof F. Improved differentiation between MS and vascular brain lesions using FLAIR* at 7?T. Eur Radiol. 2014;24:841-.CrossRef PubMed
  16.Wuerfel J, Sinnecker T, Ringelstein EB, Jarius S, Schwindt W, Niendorf T, Paul F, Kleffner I, D?rr J. Lesion morphology at 7?T MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler. 2012;18:1592-.CrossRef PubMed
  17.Sinnecker T, D?rr J, Pfueller CF, Harms L, Ruprecht K, Jarius S, Brück W, Niendorf T, Wuerfel J, Paul F. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology. 2012;79:708-4.CrossRef PubMed
  18.Geurts JJ, Calabrese M, Fisher E, Rudick RA. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol. 2012;11:1082-2.CrossRef PubMed
  19.Filippi M, Rocca MA, Calabrese M, Sormani MP, Rinaldi F, Perini P, Com
• 作者单位：M. P. Wattjes (1)
  M. D. Steenwijk MSc (1)
  M. Stangel MD (2)
  
  1. MS Center and Department of Radiology & Nuclear Medicine, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, Netherlands
  2. Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany
  
• 刊物主题：Neuroradiology; Neurosurgery; Neurology;
• 出版者：Springer Berlin Heidelberg
• ISSN：1869-1447

文摘

Magnetic resonance imaging (MRI) is the most powerful tool for the early (differential) diagnosis of multiple sclerosis (MS) and has been part of the International Panel criteria (2001, 2005, 2010) for more than 10 years. The role of brain and spinal cord MRI in the diagnosis of MS is well established. New MR techniques and markers will further improve the diagnostic value in a research and clinical routine setting. In addition to diagnosis, MRI is widely used for prognostic evaluation as well as treatment efficacy and safety monitoring. This field has gained importance with the introduction of new MS therapeutics. Therefore, the scope of MRI-guided MS disease monitoring has been widened to include rigorous treatment monitoring aiming at “no evidence of disease activity (NEDA)- Next, safety monitoring of treated MS patients has become major concern to enable early detection of opportunistic infections such as progressive multifocal leukoencephalopathy (PML). Driven by these new developments, recently published expert panel guidelines stressed the need for standardized imaging protocols and targeted specialized imaging markers for MS diagnosis and disease monitoring. This review article aims to give an update on the role of MRI in the diagnosis and monitoring of MS with particular emphasis to treatment efficacy and safety, both in clinical practice and in research. Keywords Multiple sclerosis MRI Disease monitoring Safety monitoring PML